Products

Borne

Uses AI

Taste Layer for AI Models

bornesociety.com AI Models & Agents / Training Data & Labeling

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$18/mo
Lower than 63% of peersNiche median $29/mo
Creators
Elliot Osborne
No social account linked
Launched
3mo ago
2026-08-14 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Taste Layer for AI Models

    Aug 14 · 3mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-07-20

KeywordMonthly volume
borne sdk530
borne settee500

Traffic data: Vaneform

Pricing

Single image
$18/once
Full database
$17.5K/once
916 images

Trial: None · 2 paid tiers ($18–$17500) · Observed 2026-11-06 · Source page

Entry price $18/mo, Lower than 63% of peers; “Training Data & Labeling” median is $29/mo.View pricing benchmark

Pages & changes

Tracked since 2026-08-14

Key pages

Weekly snapshots
bornesociety.com/ Snapshot 2026-11-06

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Borne cost?
Single image: $18/once; Full database: $17.5K/once. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Borne get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Borne and what platforms does it support?
Borne is catalogued under Training Data & Labeling: Taste Layer for AI Models. Supported platforms: Web.

Related products in this category

AI Models & Agents / Training Data & Labeling

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.